Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001161697-24-000130
Filing Date
2024-03-12
Accepted
2024-03-11 18:47:17
Documents
46
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT FOR 12-31-2023 form_10-q.htm   iXBRL 10-Q 448137
2 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION OF CEO ex_31-1.htm EX-31 10236
3 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION OF CFO ex_31-2.htm EX-31 10227
4 SECTION 1350 CERTIFICATION OF CEO ex_32-1.htm EX-32 5001
5 SECTION 1350 CERTIFICATION OF CFO ex_32-2.htm EX-32 4992
  Complete submission text file 0001161697-24-000130.txt   2985389

Data Files

Seq Description Document Type Size
6 INLINE XBRL SCHEMA FILE gstc-20231231.xsd EX-101.SCH 38668
7 INLINE XBRL CALCULATION FILE gstc-20231231_cal.xml EX-101.CAL 29257
8 INLINE XBRL DEFINITION FILE gstc-20231231_def.xml EX-101.DEF 123062
9 INLINE XBRL LABEL FILE gstc-20231231_lab.xml EX-101.LAB 274364
10 XBRL PRESENTATION FILE gstc-20231231_pre.xml EX-101.PRE 181091
48 EXTRACTED XBRL INSTANCE DOCUMENT form_10-q_htm.xml XML 300983
Mailing Address 719 JADWIN AVENUE RICHLAND WA 99352
Business Address 719 JADWIN AVENUE RICHLAND WA 99352 509-531-1671
GlobeStar Therapeutics Corp (Filer) CIK: 0001502152 (see all company filings)

EIN.: 273480481 | State of Incorp.: WY | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55072 | Film No.: 24739649
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)